🇺🇸 FDA
Pipeline program

IC51

IC51-322

Phase 3 mab completed

Quick answer

IC51 for Encephalitis is a Phase 3 program (mab) at Valneva Austria GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Valneva Austria GmbH
Indication
Encephalitis
Phase
Phase 3
Modality
mab
Status
completed

Clinical trials